5 FU PhaRes IV Injection or Infusion

5 FU PhaRes 25 mg/ml IV Injection or Infusion সম্পর্কে

বাংলাদেশে 5 FU PhaRes 25 mg/ml IV Injection or Infusion IV Injection or Infusion হিসেবে পাওয়া যায়; এতে Fluorouracil আছে (২৫ mg/ml)। Fluorouracil-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Pharma Resources। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Fluorouracil-এর ২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১টি। সবচেয়ে কম দাম 5-Fluril 25 mg/ml IV Injection or Infusion-এর, প্রতি ইউনিট ৳ ৫৫.০০।

5 FU PhaRes 25 mg/ml IV Injection or Infusion কী?

5 FU PhaRes is a brand of fluorouracil, a cytotoxic medicine given by intravenous injection or infusion. It is used in adults for cancers of the colon or rectum, stomach and pancreas, liver, breast, bladder, lung, ovary and cervix. It may be given alone or with other treatments. Because it is a highly toxic medicine with a narrow margin of safety, patients need careful supervision during treatment. The doctor decides the dose, schedule and duration, and treatment is stopped if signs of toxicity appear. The vial contains 25 mg/ml and is stored below 25°C, protected from light and not refrigerated.

5 FU PhaRes-এর ব্যবহার

5 FU PhaRes is used to treat several types of cancer. These include cancer of the colon or rectum, stomach and exocrine pancreas, liver, breast, bladder, lung, ovary and cervix. It can be given alone or in combination with other cancer treatments. Only a qualified cancer specialist decides whether this medicine is suitable, and the treatment plan is based on the type and stage of cancer and the patient's general health.

5 FU PhaRes কীভাবে ব্যবহার করবেন

5 FU PhaRes is given by a healthcare professional as an intravenous injection or infusion, usually in a hospital or clinic. It must not be self-administered. The doctor decides the dose, how often it is given and how long treatment continues, based on the patient's condition and response. The medicine may be diluted before infusion as instructed by the doctor. Patients should report any new symptoms promptly during and after treatment.

5 FU PhaRes-এর পার্শ্বপ্রতিক্রিয়া

5 FU PhaRes can cause serious side effects. These include effects on the blood, such as low white cell and platelet counts, which may raise the risk of infection or bleeding. Heart problems have been reported occasionally. Other possible effects include mouth ulcers, diarrhoea and gastrointestinal ulceration or bleeding. The doctor monitors for these and may stop treatment if they occur. Patients should tell their doctor or nurse about any unusual symptoms, such as fever, bruising, mouth sores or severe diarrhoea.

সতর্কতা ও নিরাপত্তা

5 FU PhaRes is a highly toxic medicine and must be given only under close medical supervision. It is not for people who are severely debilitated, who have bone marrow suppression from radiotherapy or chemotherapy, or who do not have cancer. It is contraindicated in pregnancy and breastfeeding, and in women who may become pregnant. Before starting treatment, tell the doctor about any medical conditions, medicines or supplements you take, especially cimetidine, and about any past heart problems. The doctor will decide if treatment is appropriate and will monitor you during the course.

সাধারণ প্রশ্ন

What is 5 FU PhaRes used for and what kind of medicine is it?

5 FU PhaRes is a cytotoxic (cancer) medicine containing fluorouracil. It is used to treat cancers of the colon or rectum, stomach, pancreas, liver, breast, bladder, lung, ovary and cervix. It is given by intravenous injection or infusion under the care of a cancer specialist, either alone or with other treatments.

How should 5 FU PhaRes be taken?

5 FU PhaRes is given by a healthcare professional as an intravenous injection or infusion, usually in a hospital or clinic. The doctor decides the dose, how often it is given and how long treatment lasts. It is not self-administered. Always follow the doctor's instructions and report any side effects promptly.

What medicines may interact with 5 FU PhaRes?

Cimetidine taken before treatment has been reported to increase blood levels of fluorouracil. Tell your doctor about all medicines, supplements and herbal products you use before starting treatment. The doctor will review possible interactions and decide if any changes are needed. Do not start or stop any medicine without asking your doctor.

What is the price of 5 FU PhaRes?

The listed price is ৳ ৪৫৭.০০.

IV Injection or Infusion
জেনেরিক নাম
Fluorouracil
শক্তি
25 mg/ml
ডোজ ফর্ম
IV Injection or Infusion
প্রস্তুতকারক
Pharma Resources
বাংলাদেশে দাম

৳ ৪৪৭.৮৬ ৳ ৪৫৭.০০ ২% ছাড় প্রতি ইউনিট

দাম হালনাগাদ: ১৮ Nov ২০২৬

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

5 FU PhaRes is indicated alone or in combination for- 
  • Carcinoma of the colon or rectum
  • Carcinoma of the stomach and exocrine pancreas
  • Carcinoma of the liver
  • Carcinoma of the breast
  • Carcinoma of the bladder
  • Carcinoma of the lung
  • Epithelial ovarian carcinoma
  • Cervical carcinoma.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Fluorouracil is inactive as such in mammalian cells but is converted into the active 5-fluorodeoxyuridine monophosphate (FdUMP) by a variety of different metabolic pathways. The drug works by inhibiting the enzyme thymidylate kinase which results in reduced formation of thymidine and thus of DNA. The active metabolite FdUMP appears to form a stable complex with the folate cofactor N-5, 10-methylene tetrahydrofolate which inactivates thymidylate kinase. Fluorouracil as FdUMP is also incorporated into RNA which results in fluorination of RNA. The effect of fluorouracil on living cells is limited mainly to those in the proliferative phase but while cells in the G2 and S phase are most affected there may be effects at any stage of the cell cycle.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Intravenous 5-fluorouracil can be delivered by rapid intravenous bolus injection or slow infusion. The vial contents can rapidly be injected directly into a peripheral vein, the commonest schedules being: 12-13.5 mg/Kg (500 mg/m2) daily for 5 days repeated at 4-weekly intervals. Slow intravenous infusion requires the drug, to be diluted in 500 ml of dextrose 5% solution, then infused over 2-3 hr on 5 successive days.

For palliative management of cancer: Initial Dose: 12 mg/kg intravenously once daily for 4 successive days. Maximum Dose: 800 mg/day. If no toxicity is observed, 6 mg/kg may be administered on the 6th, 8th, 10th, and 12th day (No therapy is given on days 5, 7, 9, or 11). Discontinue at the end of day 12, even with no apparent toxicity.

Poor risk patients and those who are not in an adequate nutritional state: Initial Dose: 6 mg/kg/day for 3 days. Maximum Dose: 400 mg/day. If no toxicity is observed, 3 mg/kg may be administered on days 5, 7, and 9 (No therapy is to be administered on days 4, 6, or 8). Discontinue at the end of day 9, even with no apparent toxicity.

Maintenance therapy: In instances where toxicity has not been a problem, it is recommended that therapy be continued using either of the following schedules:
  • Repeat the dosage of the first course every 30 days after the last day of the previous course, or
  • When the toxic signs resulting from the initial course of therapy have subsided, administer a maintenance dose of 10 to 15 mg/kg/week as a single dose. Maximum Dose: 1g/week .The reaction by the patient to the previous course of therapy should be taken into account and the dosage should be adjusted accordingly.
Usual adult dose for cervical cancer: In combination with cisplatin 1 gm/m2 IV on day 1. The cycle is repeated every 21 days.

Usual pediatric dose for malignant disease: The manufacturer has reported that the safety and effectiveness of fluorouracil have not been established in children. However, the drug has been used in children following adult guidelines.

Intra-arterial infusion: Fluorouracil has also been given by intra-arterial infusion for adult in doses of 5 to 7.5 mg/kg body weight is dissolved in 20-100 ml of 5% Dextrose solution and administered 10-20 days by using an infusion pump.

Combination with radiation: Usual adult daily dose of 5-10 mg/kg body weight is given in combination with radiation according to systemic administration method or intra-arterial infusion method.

Combination with other anticancer drugs: Fluorouracil is used alone or in combination in the adjuvant treatment of breast and gastro-intestinal cancer, and palliation of inoperable malignant neoplasms, especially those of the gastro-intestinal tract, breast, head and neck, liver, genito-urinary system, and pancreas. It is also used with cyclophosphamide and methotrexate in the combination chemotherapy of breast cancer. A usual adult dose of 5 to 10 mg/kg body weight daily is given in combination with other anticancer drugs every day or intermittently once to twice a week by systemic administration method or intra-arterial infusion method.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pre-treatment with cimetidine for 4 weeks led to increased plasma concentrations of 5 FU PhaRes following intravenous and oral administration in 6 patients. The effect was probably due to a combination of hepatic enzyme inhibition and reduced hepatic blood flow.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

It is contraindicated in patients that are severely debilitated or in patients with bone marrow suppression due to either radiotherapy or chemotherapy. It is likewise contraindicated in pregnant or breastfeeding women. It should also be avoided in patients that do not have malignant illnesses.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Potentially life-threatening effects: Severe effects from 5-5 FU PhaRes are related to the dosage and duration of therapy.

Cardiac effects: Occasional case reports associating 5-5 FU PhaRes therapy with 'ischemic cardiac events' evidence against the autoimmune phenomenon is the fact that in several cases cardiotoxicity occurred within several hours of the first dose.

Hematological effects: Potentially lethal effects caused by severe hematological toxicity may develop within the first 10 days of treatment being instituted but generally resolves within 3 weeks. At the recommended dose and schedule it is rather uncommon for hematological toxicity to be severe. Any ontribute to severe effects from 5-5 FU PhaRes on the blood-forming cells. Thus extensive prior irradiation or the concomitant use of cytotoxic drugs tend to exacerbate the severity of the hematological side effects of 5-5 FU PhaRes.

Neurological effects: Effects on the central nervous system have been occasionally reported and cerebral ataxia is dose-dependent with an incidence of between 3.1 and 7%. Acute cerebellar syndromes and myelopathy have been described following intrathecal 5-5 FU PhaRes. Neurological syndromes may occur rarely after carotid artery perfusion in head and neck cancer. Other effects Allergic reaction (including difficulty in breathing, closing of the throat, swelling of the lips, tongue, or face, or hives), decreased bone marrow function and blood problems (extreme fatigue, easy bruising or bleeding, black, bloody or tarry stools, or fever, chills, or signs of infection), hand-foot syndrome (tingling, pain, redness, swelling or tenderness of the hands and feet), severe vomiting, diarrhoea, frequent bowel movements or watery stools, or sores in the mouth or throat, or stomach pain or heartburn or black, bloody or tarry stools. Other less serious side effects may include mild to moderate nausea, vomiting or loss of appetite, balance problems, confusion, rash and itching, or temporary hair loss. Conjunctivitis, both acute and chronic can proceed to tear duct stenosis and ectropion following prolonged administration. Very chronic administration, extending beyond 3 months, of low dosage has been associated with low systemic toxicity but includes the possibility of painful and tender hands and feet associated with erythema of the extremities.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Fluorouracil is contraindicated throughout pregnancy. The literature pertaining to pregnancy and cytotoxic drugs is necessarily limited but it appears in general that risk of teratogenesis diminishes with the advancement of pregnancy. Therefore most cytotoxic drugs are absolutely contraindicated in the first trimester and 5-fluorouracil, used in the first trimester has been reported to cause multiple congenital abnormalities. There are many case reports, however, of pregnancy being conducted successfully with combination chemotherapy being given to the mother during the second and third trimesters. Because of the age of the population and the natural history of the tumors treated, most of the data on long-term follow-up pertain to therapy for leukemias. More data need to be accrued on the subsequent development of neonates before it is certain that any of these compounds are free of late effects.

It is not known whether fluorouracil is excreted in human milk. Because fluorouracil inhibits DNA, RNA and protein synthesis, mothers should not nurse while receiving this drug.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

5-5 FU PhaRes is highly toxic drug with a narrow margin of safety. Therefore patients should be carefully supervised, since therapeutic response is unlikely to occur without some evidence of toxicity. Daily dose should not exceed 1 gram. Treatment should be discontinued promptly when one of the following signs of toxicity appears: Leucopenia (WBC under 3500/mm3). Thrombocytopenia (platelet under 100000/mm3). Stomatitis ( the first small ulceration at the inner margin of the lips is a signal for stopping treatment). Severe diarrhoea (frequent bowel movements and watery stools). Gastro-intestinal ulceration and bleeding.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Cases of deliberate overdose are unknown but excessive toxicity because of the hematological effects as described above. There is no specific antidote to 5-5 FU PhaRes toxicity; treatment consists in supportive care. In addition to the hematological toxicity other toxicities will occur with overdose. Sign and symptoms are qualitatively similar to the side effects. Treatment should be performed promptly and appropriate drugs are given to control symptoms of overdose.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store the vial in original carton not exceeding 25℃. Do not refrigerate. Protect from light.

বিকল্প ব্র্যান্ড: Fluorouracil

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

5-Fluril IV Injection or Infusion

25 mg/ml

Fluorouracil

Techno Drugs Ltd.

৳ ৫৩.৯ ৳ ৫৫.০০ ২% ছাড় প্রতি ইউনিট

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।